The action of a single gene is necessary to maintain a lifelong supply of stem cells that make bone healing possible, according to a new study. These immature cells normally either keep dividing to replenish a reserve pool, known as self-renewal, or mature into cells with a specific job, such as bone-building; once mature, they generally can’t reverse course, so the supply is finite and shrinks further with age.
Led by NYU Langone Health researchers, the new study, published in Science Advances, identifies a gene called HOXA10 as a lifelong guardian of that stem cell supply, keeping cells from maturing into bone-building cells called osteoblasts until they’re actually needed for healing.
Deleting HOXA10 in 6-day-old mouse pups and tracking their bone stem cells for the next 15 months, the researchers found 90 percent of the stem cells and descendants that should have been present were gone, the result of lost self-renewal.
“Most bone research asks how stem cells become bone. We asked how they remain as stem cell replacements in the first place. Without the study gene, bone burns through its reserves too early, which is what we see in aging bone,” corresponding author Philipp Leucht explained.
“Our study shows that HOXA10 protects healing capacity normally by acting as a brake on premature maturation,” said Dr. Leucht. “To our knowledge, this study is the first to assign a definitive role for HOX genes in the active maintenance of adult skeletal stem cells.”
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Mice lacking HOXA10 also couldn’t heal properly after a bone break: in the callus—the temporary tissue bridge spanning a break as it heals—only 48 percent of cells were stem cell progenitors, versus 76 percent in control mice with a working copy of the gene.
Deleting the gene also left the collagen proteins that form bone’s early rebuilding framework disorganized, a problem since that scaffold must line up neatly, rather than form a tangled mesh, for new bone to harden with calcium.
Testing human bone biopsies with three related HOX genes silenced at once, the researchers saw similar but sharper effects: stem cell numbers dropped further, and programmed cell death rose 50 percent, suggesting human stem cells may depend even more on HOX genes for long-term self-renewal, Dr. Leucht added.
To track the cells, the team tagged HOXA10-expressing mouse stem cells with a fluorescent marker that could be switched off on command, monitoring their status at every life stage; the cells outperformed others in the periosteum, the membrane covering most bones, at generating new colonies, a standard test of self-renewal. HOX genes are known for encoding proteins that work like the body’s “zip code,” marking limb position in the womb. The findings build on a 2023 study, also led by Dr. Leucht, showing that boosting HOXA10 activity could improve fracture healing in older mice.
“Our study identifies HOXA10 as a preserver of skeletal stem cell pools over time by promoting self-renewal, suppressing premature maturation, and lining up the protein fibers in a break so that the two ends of broken bone can knit,” said Dr. Leucht. “The findings establish HOX genes as potential therapeutic targets for enhancing bone regeneration.”